Mounjaro (tirzepatide) is one of the latest therapies to be launched in the UK for weight management in patients with severe obesity and related health conditions. Its launch was highly anticipated, offering an alternative to existing medications and demonstrating encouraging results in clinical trials.

Understanding Mounjaro Dosages and Suitability

Mounjaro is not a one-size-fits-all medication. It is prescribed in a series of escalating doses to ensure patient safety and maximize effectiveness:

2.5 mg: Starting dose for the first month to help the body adjust and reduce side effects.

5 mg: Initial maintenance dose for continued treatment.

7.5 mg: Intermediate level for patients who need greater appetite control.

10 mg: Higher maintenance dose for those requiring additional weight loss.

12.5 mg: Advanced titration step for patients tolerating 10 mg well.

15 mg: Maximum licensed dose, used only under specialist monitoring.

Doctors decide which dosage is appropriate based on individual response and tolerance, gradually adjusting until an effective balance is found.

How the NHS Provides Mounjaro?

The NHS rollout of Mounjaro is happening in stages. Initially, it is being offered through specialist weight management services rather than routine GP prescriptions. This means access is usually coordinated through hospital-based obesity clinics or referral programmes. Because supply is limited and demand is high, priority is given to patients with the most urgent health risks. The medication is dispensed alongside lifestyle support such as dietary advice, counselling, and structured physical activity programmes to ensure sustainable results.

Eligibility Criteria

To qualify for Mounjaro under the NHS, patients must meet strict eligibility rules set by the National Institute for Health and Care Excellence (NICE). These typically include:

A body mass index (BMI) of 35 or higher, combined with at least one obesity-related condition such as type 2 diabetes, high blood pressure, or sleep apnoea.

How to Apply for NHS Access

Applying for Mounjaro requires several steps:

Speak to your GP: Your first step is to book an appointment with your general practitioner. Be prepared to discuss your weight history, any underlying health conditions, and previous weight-loss attempts.

Referral to specialist services: If you meet the initial criteria, your GP can refer you to an NHS weight management service or hospital obesity clinic.

Decision and treatment plan: If approved, you will begin treatment under close monitoring, starting at 2.5 mg and gradually increasing your dose. You will also be supported with diet and lifestyle advice.

Conclusion

Mounjaro represents a major development in obesity treatment, offering real hope to patients struggling with weight-related health issues. Access through the NHS, however, is not automatic. By understanding the available dosages, how the rollout works, the eligibility requirements, and the application process, patients can better prepare for discussions with their GP and increase their chances of joining the programme. For those who qualify, Mounjaro could be a life-changing treatment — improving not only physical health but also long-term quality of life.

Thanks for reading!